Toralgen Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.7M
- Investors
-
4
Toralgen General Information
Description
Operator of a preclinical stage biopharmaceutical company intended to focus on the development and commercialization of human therapeutics. The company offers a poly-bile nano-particle platform that eliminates the challenges of oral delivery to fabricate nano-pill and improve outcomes through optimized and targeted drug delivery, enabling healthcare providers to improve the lives of their patients.
Contact Information
Website
www.toralgen.comCorporate Office
- 1220 Waterway Boulevard
- Suite H123
- Indianapolis, IN 46202
- United States
Corporate Office
- 1220 Waterway Boulevard
- Suite H123
- Indianapolis, IN 46202
- United States
Toralgen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Feb-2025 | $4.7M | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 22-Oct-2020 | Completed | Pre-Clinical Trials |
Toralgen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Toralgen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Toralgen Patents
Toralgen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026064396-A1 | Nanoparticle complexes and therapeutic uses therefor | Pending | 17-Sep-2024 |
Toralgen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Toralgen Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elevate Ventures | Venture Capital | Minority | ||
| Solyco Capital | PE/Buyout | Minority | ||
| Talon Group | PE/Buyout | Minority | ||
| VisionTech Partners | Angel Group | Minority |
Toralgen FAQs
-
When was Toralgen founded?
Toralgen was founded in 2017.
-
Where is Toralgen headquartered?
Toralgen is headquartered in Indianapolis, IN.
-
What is the size of Toralgen?
Toralgen has 9 total employees.
-
What industry is Toralgen in?
Toralgen’s primary industry is Drug Delivery.
-
Is Toralgen a private or public company?
Toralgen is a Private company.
-
What is Toralgen’s current revenue?
The current revenue for Toralgen is .
-
How much funding has Toralgen raised over time?
Toralgen has raised $13M.
-
Who are Toralgen’s investors?
Elevate Ventures, Solyco Capital, Talon Group, and VisionTech Partners have invested in Toralgen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
